The effects of hyperthermia on human endothelial monolayers: modulation of thrombotic potential and permeability.
The effects of hyperthermia on potentially prothrombotic endothelial function were investigated by measuring levels of von Willebrand factor, thrombospondin, tissue plasminogen activator and plasminogen activator inhibitor-1 secreted by unstimulated human umbilical vein endothelial cells cultured at 37 degrees C, 39 degrees C, 41 degrees C and 43 degrees C for 24 h. Endothelial barrier function at 43 degrees C was compared with that at 37 degrees C by measuring permeability to radiolabelled human serum albumin and low density lipoprotein. Thrombospondin levels were unaffected by a temperature of 39 degrees C; they increased after 3 h at 41 degrees C and subsequently declined to values significantly below the 37 degrees C control. At 43 degrees C, secretion exhibited a time-dependent decrease. Secretion of von Willebrand factor was not discernibly affected by exposure to 39 degrees C or 41 degrees C. Its response to 43 degrees C resembled that of thrombospondin to 41 degrees C. In contrast, elevated temperatures markedly increased plasminogen activator inhibitor-1 while decreasing t-PA secretion, though after prolonged exposure to 43 degrees C the levels of both returned to control values. After 12-24 h at 43 degrees C, endothelial permeability to both albumin and low density lipoprotein increased markedly. Vascular endothelium may contribute to the thrombotic tendency associated with heat stroke by increasing access to the prothrombotic subendothelium and reducing fibrinolysis.
Ang
C
C
Heart Research Institute, Camperdown, NSW, Australia.
Dawes
J
J
D001833:Body Temperature Regulation / Q000502:physiology*; D002199:Capillary Permeability / Q000502:physiology*; D015815:Cell Adhesion Molecules / Q000032:analysis; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000503:physiopathology*; D006358:Hot Temperature; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism; D013927:Thrombosis / Q000503:physiopathology*; D019699:Thrombospondins; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014841:von Willebrand Factor / Q000378:metabolism
D015815:Cell Adhesion Molecules; D008077:Lipoproteins, LDL; D008562:Membrane Glycoproteins; D017395:Plasminogen Activator Inhibitor 1; D012709:Serum Albumin; D019699:Thrombospondins; D014841:von Willebrand Factor; D010959:Tissue Plasminogen Activator